PT-141 Research Guide: Melanocortin Receptor Agonist Analysis
PT-141 activates melanocortin-4 receptors in the hypothalamus with 10,000-fold greater selectivity than α-MSH, triggering central nervous system pathways within 45 minutes of administration. Laboratory research reveals distinct mechanisms affecting libido, appetite regulation, and cardiovascular function through cAMP-dependent signaling cascades.